Drugplain

ORENCIA 50 mg/.4mL

abatacept · INJECTION, SOLUTION · E.R. Squibb & Sons, L.L.C.

No Recall History
Plain English

ORENCIA is a injection, solution containing abatacept at 50 mg/.4mL, taken subcutaneous. Manufactured by E.R. Squibb & Sons, L.L.C..

Key Facts

Brand Name
ORENCIA
Generic Name
abatacept
NDC Code (Product)
0003-2814
Manufacturer
E.R. Squibb & Sons, L.L.C.
Strength
50 mg/.4mL
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Marketing Status
Application #
BLA125118
Drug Class
Selective T Cell Costimulation Modulator [EPC]
Marketing Start
07/29/2011

Recall History

No Recall History

Frequently Asked Questions

What is ORENCIA used for?

ORENCIA contains abatacept. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.

Is ORENCIA a controlled substance?

ORENCIA is not classified as a controlled substance by the DEA.

What is the generic name for ORENCIA?

The generic name for ORENCIA is abatacept. There are no other listed brand versions of abatacept.

What is the NDC code for ORENCIA 50 mg/.4mL?

The NDC (National Drug Code) for ORENCIA 50 mg/.4mL is 0003-2814, listed by E.R. Squibb & Sons, L.L.C..

Product NDC

0003-2814

Package NDC

0003-2814-11

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)